Selling And Administration Expenses Cambiamento Data
ANI Pharmaceuticals USD 44.46M 2.46M 2023-12
Aurora Cannabis CAD 43.79M 774K 2023-03
Bausch Health Companies USD 715M 4M 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Canopy Growth CAD 60.33M 26.29M 2023-09
Catalent USD 250M 45M 2023-12
Corcept Therapeutics USD 47.15M 1.89M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Merck USD 2.75B 272M 2023-12
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Novo Nordisk DKK 14.08B 1.34B 2023-09
Pacira USD 65.8M 2.15M 2023-12
Perrigo USD 304M 28.3M 2023-09
Phibro Animal Health USD 68.45M 15.55M 2023-09
Prestige Brands USD 65.47M 630K 2023-12
Supernus Pharmaceuticals USD 81.28M 1.42M 2023-12
Zoetis USD 565M 40M 2023-12



Novo Nordisk Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.